BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16696647)

  • 1. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
    Levitz SM; Specht CA
    FEMS Yeast Res; 2006 Jun; 6(4):513-24. PubMed ID: 16696647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors.
    Mansour MK; Schlesinger LS; Levitz SM
    J Immunol; 2002 Mar; 168(6):2872-9. PubMed ID: 11884457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein.
    Specht CA; Nong S; Dan JM; Lee CK; Levitz SM
    J Infect Dis; 2007 Sep; 196(5):796-800. PubMed ID: 17674324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells.
    Mansour MK; Latz E; Levitz SM
    J Immunol; 2006 Mar; 176(5):3053-61. PubMed ID: 16493064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.
    Huang C; Nong SH; Mansour MK; Specht CA; Levitz SM
    Infect Immun; 2002 Oct; 70(10):5485-93. PubMed ID: 12228274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.
    Levitz SM; Nong S; Mansour MK; Huang C; Specht CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10422-7. PubMed ID: 11504924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.
    Pietrella D; Corbucci C; Perito S; Bistoni G; Vecchiarelli A
    Infect Immun; 2005 Feb; 73(2):820-7. PubMed ID: 15664921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes.
    Syme RM; Spurrell JC; Amankwah EK; Green FH; Mody CH
    Infect Immun; 2002 Nov; 70(11):5972-81. PubMed ID: 12379672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection.
    Dan JM; Kelly RM; Lee CK; Levitz SM
    Infect Immun; 2008 Jun; 76(6):2362-7. PubMed ID: 18391001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two novel cryptococcal mannoproteins recognized by immune sera.
    Biondo C; Messina L; Bombaci M; Mancuso G; Midiri A; Beninati C; Cusumano V; Gerace E; Papasergi S; Teti G
    Infect Immun; 2005 Nov; 73(11):7348-55. PubMed ID: 16239533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recognition of Cryptococcus neoformans by Pattern Recognition Receptors and its Role in Host Defense to This Infection].
    Sato K; Kawakami K
    Med Mycol J; 2017; 58(3):J83-J90. PubMed ID: 28855484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated recognition of Cryptococcus neoformans.
    Levitz SM
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(3):133-6. PubMed ID: 12145626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides.
    Dan JM; Wang JP; Lee CK; Levitz SM
    PLoS One; 2008 Apr; 3(4):e2046. PubMed ID: 18446192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-glycosylation converts non-glycoproteins into mannose receptor ligands and reveals antigen-specific T cell responses in vivo.
    Kreer C; Kuepper JM; Zehner M; Quast T; Kolanus W; Schumak B; Burgdorf S
    Oncotarget; 2017 Jan; 8(4):6857-6872. PubMed ID: 28036287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dectin-2-mediated signaling triggered by the cell wall polysaccharides of Cryptococcus neoformans.
    Tanno D; Yokoyama R; Kawamura K; Kitai Y; Yuan X; Ishii K; De Jesus M; Yamamoto H; Sato K; Miyasaka T; Shimura H; Shibata N; Adachi Y; Ohno N; Yamasaki S; Kawakami K
    Microbiol Immunol; 2019 Dec; 63(12):500-512. PubMed ID: 31544981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a 105 kilodalton Cryptococcus neoformans mannoprotein involved in human cell-mediated immune response.
    Pitzurra L; Vecchiarelli A; Peducci R; Cardinali A; Bistoni F
    J Med Vet Mycol; 1997; 35(4):299-303. PubMed ID: 9292430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and purification of antigenic components of Cryptococcus.
    Wozniak KL; Levitz SM
    Methods Mol Biol; 2009; 470():71-83. PubMed ID: 19089377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses.
    Bauman SK; Nichols KL; Murphy JW
    J Immunol; 2000 Jul; 165(1):158-67. PubMed ID: 10861048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The F-Box Protein Fbp1 Shapes the Immunogenic Potential of
    Masso-Silva J; Espinosa V; Liu TB; Wang Y; Xue C; Rivera A
    mBio; 2018 Jan; 9(1):. PubMed ID: 29317510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.